三博脑科收盘上涨1.59%，滚动市盈率92.60倍，总市值101.53亿元

Group 1 - The core viewpoint of the article highlights the performance and market position of Sanbo Brain Science, noting its significant growth in revenue and net profit, alongside a high PE ratio compared to industry averages [1] - As of April 1, Sanbo Brain Science's stock closed at 49.29 yuan, with a PE ratio of 92.60 and a total market capitalization of 10.153 billion yuan [1] - The company ranks 37th in the medical services industry, which has an average PE ratio of 52.86 and a median of 49.90 [1] Group 2 - Sanbo Brain Science specializes in clinical medical services in neurology, including neurosurgery, neurointervention, and neuro-oncology treatments [1] - The company has a strong team of medical experts, which has led to a high volume of complex neurosurgeries, with 80% classified as the most difficult level [1] - For the third quarter of 2024, Sanbo Brain Science reported a revenue of 1.059 billion yuan, a year-on-year increase of 9.83%, and a net profit of 105 million yuan, reflecting a 42.93% increase [1]